Skip to main content
Clinical Trials/IRCT20190129042540N1
IRCT20190129042540N1
Completed
Phase 2

The effects of botulinum toxin type A injections on pain symptoms, quality of life and sleep quality of patients with diabetic neuropathy : A randomized double-blind clinical trial

Rafsanjan University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Diabeticr polyneuropathy.
Sponsor
Rafsanjan University of Medical Sciences
Enrollment
50
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Having type 2 diabetes for at least 3 years
  • 40\-70 years old
  • providing a positive response to four or more questions in DN4 test
  • evidence of diabetic neuropathy in lower limb electrophysiological examination

Exclusion Criteria

  • who were allergic to BTX\-A
  • using other drugs to reduce neuropathic pain
  • a history of myasthenia gravis
  • subjects with distal muscle weakness
  • kidney dysfunction
  • history of alcohol use
  • post\-operative patients
  • who initiated taking medication after the onset of the study
  • who used aminoglycosides
  • peripheral vascular obstructive disease

Outcomes

Primary Outcomes

Not specified

Similar Trials